FDA's New Guidance Proposes Flexible Use of AI in Medical Devices | Foley & Lardner LLP
On April 3, 2023, U.S. Food and Drug Administration (FDA) issued its much anticipated draft guidance, "Marketing Submission Recommendations for a Predetermined Change Control Plan for...